DV

Daniel Vatner

Assistant Professor of Medicine · Yale-New Haven Hospital

Credentials: · · ·

History

Yale-New Haven Hospital
Present

Yale Univ Sch of Med
2010–2011
Yale-New Haven Hospital
2007–2010
University of Chicago, Biochemistry and Molecular Biology
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2003–2007
Swarthmore College
1994–1998

Research

Regulation of hepatic glucose metabolism in health and disease
Review · Nature Reviews Endocrinology · 2017 · 894 citations
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Nature Medicine · 2018 · 242 citations
Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
Hepatology · 2018 · 204 citations

Gerald Shulman
29 papers
VS
Varman Samuel
21 papers
KP
Kitt Petersen
10 papers
Max Petersen
6 papers · 3 as a resident
Jonathan Bogan
4 papers
Arijeet Gattu
3 papers · 2 as a resident
DY
Dean Yimlamai
3 papers
Glenn Gerhard
3 papers
Sachin Majumdar
3 papers
SC
Sonia Caprio
3 papers
Christopher Still
2 papers
IF
Ioana Fat
2 papers

Grants

Metabolic Heterogeneity Underlying Hypertriglyceridemia in Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.3M · Yale University
2020–2026
In vivo Regulation of Lipid Flux in the Etiology of NAFLD and Insulin Resistance
National Institute of Diabetes and Digestive and Kidney Diseases · K23
Contact PI · $775.6K · Yale University
2015–2021

Clinical trials

Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes
Principal investigator · Recruiting
Yale University
2023–2026